-
1.
公开(公告)号:US20160152991A1
公开(公告)日:2016-06-02
申请号:US15040018
申请日:2016-02-10
Applicant: Yeda Research and Development Co. Ltd.
Inventor: Yitzhak PILPEL , Tamir TULLER , Sivan NAVON , Menachem RUBINSTEIN
CPC classification number: C12N15/67 , C07K14/505 , C07K14/555 , C07K14/59 , C07K14/61 , C07K14/62 , C07K14/705 , C07K14/755 , C12N9/2402 , C12N9/2465 , C12P21/02
Abstract: Isolated polynucleotides are disclosed which increase the efficiency of gene expression in a heterologous cell. The polynucleotide sequences which encode polypeptides are adapted such that the average rate of translation of the first at least about 30 amino acids is slower by at least two fold than the average rate of translation of the remaining amino acids of the polypeptide.
Abstract translation: 公开了分离的多核苷酸,其提高异源细胞中基因表达的效率。 改编编码多肽的多核苷酸序列使得第一至少约30个氨基酸的平均翻译速率比多肽的剩余氨基酸的平均翻译速度慢至少两倍。
-
2.
公开(公告)号:US20180064682A1
公开(公告)日:2018-03-08
申请号:US15798530
申请日:2017-10-31
Applicant: Yeda Research and Development Co. Ltd.
Inventor: Menachem RUBINSTEIN , Efrat DVASH-RIESENFELD
IPC: A61K31/366 , A61K31/381 , A61K31/41
Abstract: The present invention relates to the alleviation of adverse side effects resulting from statin therapy. The present invention further relates to the use of an inhibitor of leukotriene C4 (LTC4) mediated activity for alleviating at least one side effects of statin therapy.
-
3.
公开(公告)号:US20170172979A1
公开(公告)日:2017-06-22
申请号:US15118196
申请日:2015-02-18
Applicant: Yeda Research and Development Co. Ltd.
Inventor: Menachem RUBINSTEIN , Efrat DVASH-RIESENFELD
IPC: A61K31/366 , A61K31/381 , A61K31/41
CPC classification number: A61K31/366 , A61K31/166 , A61K31/192 , A61K31/381 , A61K31/404 , A61K31/41 , A61K31/426 , A61K31/47 , A61K2300/00
Abstract: The present invention relates to the alleviation of adverse side effects resulting from statin therapy. The present invention further relates to the use of an inhibitor of leukotriene C4 (LTC4) mediated activity for alleviating at least one side effects of statin therapy.
-
-